The latest announcement is out from Genscript Biotech ( (HK:1548) ).
Genscript Biotech Corporation has announced a board meeting scheduled for March 11, 2025, to discuss and approve the company’s final results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, highlighting the company’s ongoing financial management and potential shareholder returns.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on providing various biotech products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange under the stock code 1548.
YTD Price Performance: 49.61%
Average Trading Volume: 4,728
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.73B
For a thorough assessment of 1548 stock, go to TipRanks’ Stock Analysis page.